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A Novel Heterozygous Mutation in the SLCO2A1 Gene in Family
with Primary Hypertrophic Osteoarthropathy
Han Seok Choi 1, Yumie Rhee 2, Sihoon Lee 3, Sun Hwa Lee 3, So
Young Park 4. 1 Dongguk University College of Medicine, Goyang,
Republic of Korea 2 Yonsei University College of Medicine, Seoul,
Republic of Korea 3 Gachon University School of Medicine,
Incheon, Republic of Korea 4 Dankook University College of
Medicine, Seoul, Republic of Korea
Background: Primary hypertrophic osteoarthropathy (PHO), also
called pachydermoperiostosis is characterized by digital clubbing,
pachyderma, and periostosis and the precise incidence and prevalence
are still unknown. PHO has been thought to be genetically heteroge-
neous and both autosomal dominant and autosomal recessive patterns
have been suggested. In 2008, homozygous mutations in hydroxypros-
taglandin dehydrogenase (HPGD), which encodes 15-hydroxyprosta-
glandin dehydrogenase (15-PGDH) were identified as a cause of
PHO. More recently homozygous mutations in solute carrier organic
anion transporter family, member 2A1 (SLCO2A1), the gene encoding
the prostaglandin transporter were also identified in 3 Chinese families
with PHO. Although as a result of studies that followed, knowledge of
the pathomechanism of PHO has greatly improved that increased lev-
els of prostaglandin E2 (PGE2) due to the failure of its degradation are
involved, more cases and their genetic backgrounds are needed for the
comprehensive understanding of this disease.
Clinical case: The 62-year-old Asian proband, who was born to
healthy nonconsanguineous parents visited our clinic for genetic
counseling of his son. At 19 years of age, the patient presented
with enlarged hand and foot, knee joints swelling and pain and
then was referred to neurosurgeon for suspicious of acromegaly. He
got hypophysectomy but revealed no tumor lesion in the specimen.
Attention was arouse only after periosteal thickening was noticed
in the carpal, phalangeal, radial and ulnar simple X-ray, indicating
PHO as well as facial furrowing. His two younger brothers also
showed similar clinical features and we diagnosed them as PHO.
Genetic analyses of the three siblings showed no abnormality in
HPGD gene. However, we found a novel mutation in the SLCO2A1
gene as well as a known polymorphism in three affected siblings
and none in his son who seems to be normal in appearance.
Conclusion: Here we add one more inactivating mutation in
SLCO2A1 gene that causes PHO. This novel heterozygous mutation
broadens the allelic spectrum of SLCO2A1 mutations. Further clinical
study will be needed in order to validate the genotype-phenotype correla-
tions and todevelop any therapeutic options ofPHOin future.The studyofinherited monogenic diseases has contributed greatly to our mechanistic
understanding of pathogenic mutations and gene regulation and has pro-
vided tremendous knowledge toward the common goal of developing
methods for the early diagnosis and treatment of common disorders.
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This study investigates the effects of Trametes versicolor (L.:Fr.) Pilat
(TVP, also known as Yunzhi) on bone properties in diabetic rats. Forty-
five 8-week-old male Wistar rats were fed either a chow diet (control,
CON) or a high-fat diet throughout the study period of 28 days. Ani-
mals in the high-fat-diet group were injected nicotinamide and strepto-
zotocin to induce diabetes mellitus (DM). The DM rats were divided
into a group receiving distilled water (vehicle, VH) and another group
receiving TVP at 0.1 g/kg-weight by gavage. Compared to the CON
group, animals in the vehicle group demonstrated higher degree of
hyperglucemia, smaller bone volume of tibia and femur, and lower
femoral strength. Compared to the vehicle group, the TVP group dem-
onstrated significantly lower postprandial blood sugar and femoral
cortical porosity, increased bone volume of proximal tibia and femoral
bone strength, and mitigated DM-induced deterioration of proximal
tibial microarchitecture, as shown by reduced trabecular separation
and larger trabecular number. The protective effect of TVP on bone
properties was mediated through, in part, the improvement of hyper-
glycemic control in DM animals. Further study is needed to investigate
whether TVP's osteoprotective effect is related to any mechanism that
directly benefits the bone in rats with DM.
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151Abstracts for poster (translational) sessions / Osteoporosis and Sarcopenia 1 (2015) 150e151Background: Osteoporosis is defined as “Disease of low bone mass
and increase the risk of bone fracture”, and the number of estimated
patients is 13 million in Japan. Bone strength is estimated by the bone
density and quality. Bone quality is affected by bone architecture,
turnover, accumulated damage, and mineralization. The bisphospho-
nates and selective estrogen receptor modulators (SEAM) are thrown
for treatment in the current osteoporosis therapies, but effect of these
drugs is only reduction of fracture risk and determinative in improve-
ment of the bone density. On the other hand, it is reported that acti-
vated vitamin D3 and vitamin K2 improve the bone quality. But the
effect of these vitamins is poor, effective therapeutic agents for
improvement of the bone quality is required.
Objectives: The objective of this study is to determine the benefits
of Salmon cartilage proteoglycan (SPG) diet in ovariectomized rats.
Materials and method: 1. Animal experiments
Fifty 8-week-old female Sprague-Dawley rats were housed indi-
vidual cages. The rats were randomized into sham or OVX experi-
ments, and underwent either ovariectomy or sham-operation under
anesthesia with sodium pentobarbital. The rats were divided into
the following five groups.
A) SHAM: sham-operated rats/receive MF
B) OVX: ovariectomized rats/receive MF
C) Ca-less: ovariectomized rats/receive Calcium-lessness Diet
D) 5%SPG: ovariectomized rats/receive MF which includes SPG
by the 5 wt%
E) 10%SPG: ovariectomized rats/receive MF which includes SPG
by the 10 wt%
The respective groups received free access to water and Diet for
12 weeks, and the rats were sacrificed using intraperitoneal sodiumpentobarbital at 12 weeks postoperatively. Whole blood was collected
via abdominal aorta, and both side femurs were collected by surgery
extraction.
2. Serum Biochemistry analysis
Serum was separated from whole blood by centrifusion. Gla/Glu
type Osteocalcin (Takara bio. INC., Japan) and TRAP-5b (DS Pharma
Biomedical Co., Japan) were measured by EIA.
3. Peripheral quantitative computed tomography (pQCT) analysis
To evaluate bone strength and density, pQCT sectional images
were taken by XCT Research SA+ (Stratec Medizintechnik GmbH
Pforzheim, Germany). Densitometric parameters and geometric
parameters were analyzed.
4. Histopathological analysis
To evaluate bone inner structure, left side femurs were fixed in the
10% formalin for 48 h and 70% ethanol for 72 h. After Calcium was
removed by the 10% EDTA solution for 4 weeks, femurs were
embedded in the paraffin (FFPE). HE stain, Azan stain and immuno-
histochemistry were performed on FFPE sections.
Results: Gla/Glu type Osteocalcin expression showed up-regula-
tion in OVX rats. Gla/Glu type Osteocalcin expression showed
down- regulation by SPG treatment, and it was equal to sham-oper-
ated rats. Although Bone strength and density showed weak improve-
ment effect by SPG treatment, but it was not significantly. Trabecula
showed decrease in OVX rats by histopathological evaluation. Mean-
while, SPG treatment suppressed decrease of trabecula.
Conclusions: It suggested that SPG suppress destroy of trabecula,
and prevents deterioration of the bone quality. It is expected that SPG
has the preventive effect to the osteoporosis.
